CO5540368A2 - Composicion de liberacion sostenida y proceso para producirla - Google Patents
Composicion de liberacion sostenida y proceso para producirlaInfo
- Publication number
- CO5540368A2 CO5540368A2 CO03111730A CO03111730A CO5540368A2 CO 5540368 A2 CO5540368 A2 CO 5540368A2 CO 03111730 A CO03111730 A CO 03111730A CO 03111730 A CO03111730 A CO 03111730A CO 5540368 A2 CO5540368 A2 CO 5540368A2
- Authority
- CO
- Colombia
- Prior art keywords
- sustained release
- physiologically active
- release composition
- composition according
- produce
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
1.- Una composición de liberación sostenida que contiene un polímero de ácido láctico-ácido glicólico que tiene una relación de peso molecular medio en peso a pesomolecular medio en número de aproximadamente 1,90 ó menos, o una sal del mismo, y una sustancia fisiológicamente activa.2.- La composición de liberación sostenida de acuerdo con la reivindicación 1, donde la sustancia fisiológicamente activa es un péptido fisiológicamente activo.3.- La composición de liberación sostenida de acuerdo con la. reivindicación 2, donde la sustancia fisiológicamente activa es un derivado de la LH-RH.4.- La composición de liberación sostenida de acuerdo con la reivindicación 1, donde el peso molecular medio en peso de dicho polímero de ácido láctico-ácido glicólico es de aproximadamente 3.000 a aproximadamente 100.000.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001199462 | 2001-06-29 | ||
JP2001340980 | 2001-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5540368A2 true CO5540368A2 (es) | 2005-07-29 |
Family
ID=26617908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO03111730A CO5540368A2 (es) | 2001-06-29 | 2003-12-22 | Composicion de liberacion sostenida y proceso para producirla |
Country Status (32)
Country | Link |
---|---|
US (3) | US20040241229A1 (es) |
EP (2) | EP2108363A1 (es) |
JP (3) | JP5491318B2 (es) |
KR (3) | KR100988178B1 (es) |
CN (1) | CN1535141B (es) |
AR (1) | AR034640A1 (es) |
AT (1) | ATE429903T1 (es) |
AU (1) | AU2002311630B2 (es) |
BR (1) | BR0210572A (es) |
CA (1) | CA2451718C (es) |
CO (1) | CO5540368A2 (es) |
CY (1) | CY1109272T1 (es) |
CZ (1) | CZ306388B6 (es) |
DE (1) | DE60232147D1 (es) |
DK (1) | DK1399133T4 (es) |
ES (1) | ES2324156T5 (es) |
HK (1) | HK1061802A1 (es) |
HU (1) | HU230152B1 (es) |
IL (1) | IL159060A0 (es) |
MX (1) | MXPA03011440A (es) |
MY (1) | MY139606A (es) |
NO (1) | NO333531B1 (es) |
NZ (1) | NZ529968A (es) |
PE (1) | PE20030069A1 (es) |
PL (1) | PL212531B1 (es) |
PT (1) | PT1399133E (es) |
RU (2) | RU2297240C2 (es) |
SI (1) | SI1399133T2 (es) |
SK (1) | SK287568B6 (es) |
TW (1) | TWI225416B (es) |
WO (1) | WO2003002091A2 (es) |
ZA (1) | ZA200309153B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1532985T (pt) | 2002-06-25 | 2017-01-20 | Takeda Pharmaceuticals Co | Processo de produção de uma composição de libertação sustentada |
WO2004029129A1 (ja) * | 2002-09-24 | 2004-04-08 | Asahi Kasei Chemicals Corporation | グリコール酸共重合体及びその製造方法 |
TW200529890A (en) | 2004-02-10 | 2005-09-16 | Takeda Pharmaceutical | Sustained-release preparations |
TW200613012A (en) * | 2004-07-02 | 2006-05-01 | Takeda Pharmaceuticals Co | Sustained-release composition, process for producing the same and use of the same |
ATE382337T1 (de) * | 2005-04-28 | 2008-01-15 | Nipro Corp | Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer |
JP5242415B2 (ja) | 2006-01-18 | 2013-07-24 | フォアシーエイサー ファーマシューティカルズ インコーポレイテッド | 高い安定性を持つ薬理組成物 |
EA016176B1 (ru) | 2006-12-18 | 2012-02-28 | Такеда Фармасьютикал Компани Лимитед | Композиция с замедленным высвобождением и способ её получения |
LT3660073T (lt) | 2007-02-15 | 2023-10-10 | Tolmar International Limited | Poli(laktidas-ko-glikolidas) su lėtu pradiniu atsipalaidavimu |
KR101008462B1 (ko) * | 2007-07-26 | 2011-01-14 | 조남열 | 치어류 이동용 어도 장치 |
KR100969641B1 (ko) * | 2007-11-12 | 2010-07-14 | 민선영 | 저수지의 제방용 어도 |
KR100969642B1 (ko) * | 2007-11-15 | 2010-07-12 | 민선영 | 하천의 보용 어도 |
US8641900B2 (en) | 2009-11-05 | 2014-02-04 | Taiwan Biotech Co., Ltd | Method and device for continuously preparing microspheres, and collection unit thereof |
TWI477266B (zh) * | 2009-11-05 | 2015-03-21 | Taiwan Biotech Co Ltd | 連續製備微粒的方法、裝置及其收集單元 |
EP2697361A1 (en) * | 2011-04-11 | 2014-02-19 | Cellcura Asa | Protein-free culture media products for manufacturing viral-based vaccines |
JP6246712B2 (ja) | 2012-07-12 | 2017-12-13 | 武田薬品工業株式会社 | マイクロカプセル粉末の製造方法 |
RU2572992C2 (ru) * | 2012-08-28 | 2016-01-20 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" | Способ получения микрокапсул водорастворимых препаратов пестицидов |
US10011681B2 (en) | 2013-04-11 | 2018-07-03 | Mitsui Chemicals, Inc. | Process for producing a lactic acid-glycolic acid copolymer or a salt thereof |
RU2537248C1 (ru) * | 2013-05-24 | 2014-12-27 | Екатерина Евгеньевна Быковская | Способ получения микрокапсул гетероциклических соединений триазинового ряда |
RU2537173C1 (ru) * | 2013-05-24 | 2014-12-27 | Александр Александрович Кролевец | Способ получения микрокапсул гетероциклических соединений триазинового ряда |
WO2015088990A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
CN106456704A (zh) | 2014-04-16 | 2017-02-22 | Veyx-药物有限公司 | 兽药组合物和其应用 |
TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
CN104224731A (zh) * | 2014-09-11 | 2014-12-24 | 北京天晟泰丰医药科技有限公司 | 一种不含致敏性辅料的九肽微球的制备方法 |
JP5938762B1 (ja) | 2015-09-01 | 2016-06-22 | 日揮株式会社 | マイクロカプセル製剤及びその製造方法 |
CN110856690A (zh) * | 2018-08-22 | 2020-03-03 | 深圳善康医疗健康产业有限公司 | 一种植入剂包膜及干燥装置 |
WO2021234731A1 (en) * | 2020-05-18 | 2021-11-25 | Dr Reddy's Institute Of Life Sciences | Sustained release compositions |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
JPH0678425B2 (ja) | 1984-07-06 | 1994-10-05 | 和光純薬工業株式会社 | 重合体の新規製造法 |
CA1236641A (en) | 1984-07-06 | 1988-05-10 | Motoaki Tanaka | Copolymer of lactic acid and glycolic acid and method for producing same |
JPH0720859B2 (ja) | 1985-02-07 | 1995-03-08 | 武田薬品工業株式会社 | マイクロカプセルの製造法 |
EP0190833B1 (en) | 1985-02-07 | 1991-03-27 | Takeda Chemical Industries, Ltd. | Method for producing microcapsule |
JP2551756B2 (ja) | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
US5110904A (en) | 1989-08-07 | 1992-05-05 | Abbott Laboratories | Lhrh analogs |
EP0328089A3 (en) | 1988-02-10 | 1990-11-28 | Abbott Laboratories | Reduced size lhrh analogs |
DE69129770T2 (de) * | 1990-04-13 | 1998-11-19 | Takeda Chemical Industries Ltd | Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung |
JP3200706B2 (ja) | 1990-04-13 | 2001-08-20 | 武田薬品工業株式会社 | 生体内分解型高分子重合物 |
DE69220317T2 (de) * | 1991-10-01 | 1997-10-16 | Takeda Chemical Industries Ltd | Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe |
JP3277342B2 (ja) * | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
NZ260909A (en) * | 1993-07-05 | 1995-04-27 | Takeda Chemical Industries Ltd | Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution |
JP3761594B2 (ja) * | 1993-07-05 | 2006-03-29 | 武田薬品工業株式会社 | 徐放性製剤の製造法 |
JPH08259460A (ja) | 1995-01-23 | 1996-10-08 | Takeda Chem Ind Ltd | 徐放性製剤の製造法 |
CA2192782C (en) * | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
JPH11269094A (ja) | 1998-01-16 | 1999-10-05 | Takeda Chem Ind Ltd | 徐放性組成物、その製造法および用途 |
NZ505651A (en) * | 1998-01-16 | 2003-08-29 | Takeda Chemical Industries Ltd | Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer |
JP3716146B2 (ja) * | 1998-12-15 | 2005-11-16 | 武田薬品工業株式会社 | ポリマーの製造方法 |
ATE289205T1 (de) † | 1998-12-15 | 2005-03-15 | Takeda Pharmaceutical | Verfahren zur herstellung biologisch-abbaubarer polyester |
JP2002114667A (ja) | 2000-10-11 | 2002-04-16 | Ltt Institute Co Ltd | 徐放性製剤用組成物、その製造法および徐放性マイクロカプセル製剤 |
AR034641A1 (es) * | 2001-06-29 | 2004-03-03 | Takeda Pharmaceutical | Composicion de liberacion controlada y metodo para producirla |
PT1532985T (pt) * | 2002-06-25 | 2017-01-20 | Takeda Pharmaceuticals Co | Processo de produção de uma composição de libertação sustentada |
-
2002
- 2002-06-25 TW TW091113853A patent/TWI225416B/zh not_active IP Right Cessation
- 2002-06-26 AR ARP020102405A patent/AR034640A1/es not_active Application Discontinuation
- 2002-06-27 MY MYPI20022432A patent/MY139606A/en unknown
- 2002-06-27 PE PE2002000577A patent/PE20030069A1/es not_active Application Discontinuation
- 2002-06-28 EP EP09155256A patent/EP2108363A1/en not_active Withdrawn
- 2002-06-28 SK SK1561-2003A patent/SK287568B6/sk unknown
- 2002-06-28 SI SI200230837T patent/SI1399133T2/sl unknown
- 2002-06-28 WO PCT/JP2002/006526 patent/WO2003002091A2/en active Application Filing
- 2002-06-28 MX MXPA03011440A patent/MXPA03011440A/es active IP Right Grant
- 2002-06-28 DK DK02738837.0T patent/DK1399133T4/da active
- 2002-06-28 KR KR1020097017747A patent/KR100988178B1/ko active IP Right Grant
- 2002-06-28 US US10/479,516 patent/US20040241229A1/en not_active Abandoned
- 2002-06-28 CZ CZ2003-3492A patent/CZ306388B6/cs not_active IP Right Cessation
- 2002-06-28 KR KR10-2003-7017111A patent/KR20040018401A/ko active Search and Examination
- 2002-06-28 PT PT02738837T patent/PT1399133E/pt unknown
- 2002-06-28 CN CN028130413A patent/CN1535141B/zh not_active Expired - Lifetime
- 2002-06-28 RU RU2004102503/15A patent/RU2297240C2/ru active
- 2002-06-28 BR BR0210572-1A patent/BR0210572A/pt not_active Application Discontinuation
- 2002-06-28 CA CA2451718A patent/CA2451718C/en not_active Expired - Fee Related
- 2002-06-28 AT AT02738837T patent/ATE429903T1/de active
- 2002-06-28 AU AU2002311630A patent/AU2002311630B2/en not_active Expired
- 2002-06-28 KR KR1020097017748A patent/KR20090096755A/ko not_active Application Discontinuation
- 2002-06-28 IL IL15906002A patent/IL159060A0/xx active IP Right Grant
- 2002-06-28 ES ES02738837T patent/ES2324156T5/es not_active Expired - Lifetime
- 2002-06-28 EP EP02738837A patent/EP1399133B2/en not_active Expired - Lifetime
- 2002-06-28 NZ NZ529968A patent/NZ529968A/en not_active IP Right Cessation
- 2002-06-28 PL PL367491A patent/PL212531B1/pl not_active IP Right Cessation
- 2002-06-28 HU HU0400382A patent/HU230152B1/hu unknown
- 2002-06-28 DE DE60232147T patent/DE60232147D1/de not_active Expired - Lifetime
-
2003
- 2003-11-25 ZA ZA2003/09153A patent/ZA200309153B/en unknown
- 2003-12-19 NO NO20035737A patent/NO333531B1/no not_active IP Right Cessation
- 2003-12-22 CO CO03111730A patent/CO5540368A2/es not_active Application Discontinuation
-
2004
- 2004-07-05 HK HK04104826.8A patent/HK1061802A1/xx not_active IP Right Cessation
-
2006
- 2006-12-05 RU RU2006143104/15A patent/RU2434644C2/ru active
-
2007
- 2007-12-19 US US11/960,114 patent/US8258252B2/en not_active Expired - Lifetime
-
2009
- 2009-07-29 CY CY20091100808T patent/CY1109272T1/el unknown
-
2010
- 2010-08-11 JP JP2010180145A patent/JP5491318B2/ja not_active Expired - Lifetime
-
2012
- 2012-02-15 JP JP2012030788A patent/JP5860300B2/ja not_active Expired - Lifetime
- 2012-08-02 US US13/564,928 patent/US20120295848A1/en not_active Abandoned
-
2014
- 2014-09-10 JP JP2014184482A patent/JP5931147B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5540368A2 (es) | Composicion de liberacion sostenida y proceso para producirla | |
CO5540367A2 (es) | Composicion de liberacion controlada y metodo para producirla | |
TR199801996A2 (xx) | Pirazol t�revleri, �retimi ve ila� olarak kullan�m� | |
ATE321533T1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen | |
NO20034359L (no) | Höystyrke bioresorberbare sammensetninger som inneholder polyglykolsyre | |
CY1108085T1 (el) | Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπ-2-εν-1-ονης παρασκευη και χρησης αυτων | |
DE59309388D1 (de) | Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung | |
NO20024733D0 (no) | Hydrofile molekyl¶rdisperse lösninger av karvedilol | |
TR200302105T4 (tr) | Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları. | |
ATE287705T1 (de) | Wärmegellierende bioabbaubare wässrige polymerlösung | |
PE20110236A1 (es) | Proteccion y mejoramiento de celulas, tejidos y organos que responden a la eritropoyetina | |
DE60214173D1 (de) | Negativ geladenes amphiphiles blockcopolymer als arzneistoffträger und komplex davon mit postitiv geladenem arzneistoff | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
CY1105020T1 (el) | Υποκαταστατες διαζεπανες | |
GB0328168D0 (en) | Biodegradable hyaluronic acid derivative and biodegradable polymeric micelle composition | |
CY1109013T1 (el) | Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν | |
IS7908A (is) | Ný notkun dextransúlfats | |
TW200613012A (en) | Sustained-release composition, process for producing the same and use of the same | |
UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
CO5140079A1 (es) | Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo | |
ATE365183T1 (de) | Positiv geladenes amphiphiles blockcopolymer als arzneistoffträger und komplex davon mit negativ geladenem arzneistoff | |
ATE427737T1 (de) | Mikroemulsionen von retinoiden und diese enthaltende pharmazeutische zusammensetzungen | |
AR031649A1 (es) | Composicion farmaceutica de dronedarona para administracion parenteral | |
AR033918A1 (es) | Composicion para acelerar la soldadura de una fractura osea | |
AR034044A1 (es) | Composicion para el tratamiento reconstituyente en enfermedades de cartilago |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |